About

Board of Directors

Frank Knuettel II

Chief Executive Officer, President and Director

Mr. Knuettel has decades of experience in working with and advising public and private companies on financial management and controls, M&A, capital markets transactions and operating and financial restructurings. Mr. Knuettel was formerly Director of Capital and Advisory at Viridian Capital Advisors. He joined Veridian from One Cannabis Group ("OCG"), a leading cannabis dispensary franchisor, with over thirty cannabis dispensaries sold across seven states. At OCG, Mr. Knuettel was the Chief Financial Officer where he was responsible for all finance and accounting management. Prior to OCG, Mr. Knuettel was CFO at MJardin, a Denver-based cannabis cultivation and dispensary management company, where he led the company's IPO on the Canadian Securities Exchange. Following the IPO, Mr. Knuettel managed the merger with GrowForce, a Toronto-based cannabis cultivator, after which he moved over to the Chief Strategy Role. In his role as CSO, he managed the acquisition of several private companies before recommending and executing the consolidation of management and other operations to Toronto and the closure of the executive office in Denver. Prior to MJardin, Mr. Knuettel held numerous CFO and CEO positions at early-stage companies where he had significant experience both building and restructuring businesses. Mr. Knuettel graduated cum laude from Tufts University with a B.A. degree in Economics and from The Wharton School at the University of Pennsylvania with an M.B.A. in Finance and Entrepreneurial Management.

Nicholas Kovacevich

Chairman of the Board

Mr. Kovacevich is the CEO of KushCo Holdings, Inc., a leading provider of ancillary products and services to businesses in the legal cannabis industry.

Committees

Committee Role
Governance and Nominating Committee Chair
Audit Committee Member
Compensation Committee Member

Ira E. Ritter

Director

Mr. Ritter co-founded Ritter Pharmaceuticals, Inc. and served as Chief Strategic Officer and Executive Chairman from its 2004 inception through its sale in 2020. Mr. Ritter has extensive experience creating and building diverse business enterprises, as well as, providing corporate management, strategic planning and financial consulting for a wide range of market segments including; health and beauty product national distribution (Quality King Distributors Inc.), private label production (General Nutrition Centers Inc. and K-Mart Inc.), television broadcast, programming and subscription television (ON-TV/Oak Media division of Oak Industries) and publisher of national consumer magazines and bestseller books.

He assisted taking Ritter Pharmaceuticals public on Nasdaq and Martin Lawrence Galleries public on the New York Stock Exchange.  Since 2010, Mr. Ritter also is a managing partner of Stonehenge Partners. Presently he is on the Board of Directors for Qualigen Therapeutics, Inc. and on the Advisory Board for Pepperdine’s Graziadio Business School of Social Entrepreneurship and Change. He has served as Board of Director for Vitavis Laboratories and SCWorx.

Mr. Ritter has a long history of public service including appointments by three California Governors to several State Commissions including eight years as Commissioner on the California Prison Industry Authority. He has guest lectured at University of Southern California Marshall School of Business and Pepperdine University Graziadio School of Business.

Committees

Committee Role
Compensation Committee Chair
Audit Committee Member
Governance and Nominating Committee Member

Tiffany Davis

Director

Tiffany Davis has over 20 years of experience as a financial professional working as an executive in the cannabis sector and prior to that, in consulting and private equity. Ms. Davis currently serves as Chief Executive Officer and Chief Financial Officer of Generation Alpha and prior to her appointment as CEO in October 2019, was Generation Alpha’s Chief Operating Officer from February 2018. From 2016 through 2017, Ms. Davis worked as a senior executive for a US based cannabis consulting group supporting legal grows, assisting in license applications, developing programs for cultivators, business structuring for medical dispensaries, including developing M&A opportunities, and development of plans for several cannabis start-up ventures.

Beginning in 2012 into 2016 Ms. Davis worked as a Group Vice President for a US based private equity group, performing due diligence tasks resulting in placing hundreds of millions of dollars in equity and debt instruments. From 2009 to 2011 Ms. Davis was a Manager of Corporate Advisory for Grant Thornton, focusing on accounting and supply chain services during the automotive crisis in the US, specifically on the Chrysler turnaround project. From 2005-2008 Ms. Davis worked for an international technology sector company with $500 million in revenues as a Vice President of Special Projects for an automobile parts sourcing project in India from the company’s headquarters in Chicago, Il. Ms. Davis received her B.S. from DePaul University in 2002 and an MBA from University of Chicago Graduate School of Business in 2009.

Committees

Committee Role
Audit Committee Chair
Compensation Committee Member
Governance and Nominating Committee Member